Nordea Investment Management AB decreased its holdings in UiPath, Inc. (NYSE:PATH – Free Report) by 2.7% during the second quarter, HoldingsChannel.com reports. The firm owned 287,681 shares of the company’s stock after selling 8,078 shares during the quarter. Nordea Investment Management AB’s holdings in UiPath were worth $3,677,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of PATH. AdvisorNet Financial Inc increased its stake in UiPath by 320.4% in the second quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock worth $32,000 after purchasing an additional 1,887 shares during the period. GAMMA Investing LLC increased its stake in UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock worth $38,000 after purchasing an additional 969 shares during the period. IFP Advisors Inc increased its stake in UiPath by 508.0% in the second quarter. IFP Advisors Inc now owns 3,283 shares of the company’s stock worth $42,000 after purchasing an additional 2,743 shares during the period. Brooklyn Investment Group grew its position in shares of UiPath by 314.3% during the 1st quarter. Brooklyn Investment Group now owns 4,508 shares of the company’s stock worth $46,000 after buying an additional 3,420 shares in the last quarter. Finally, Bayforest Capital Ltd grew its position in shares of UiPath by 852.4% during the 2nd quarter. Bayforest Capital Ltd now owns 4,143 shares of the company’s stock worth $53,000 after buying an additional 3,708 shares in the last quarter. Hedge funds and other institutional investors own 62.50% of the company’s stock.
UiPath Price Performance
Shares of PATH stock opened at $16.29 on Wednesday. UiPath, Inc. has a 1-year low of $9.38 and a 1-year high of $18.74. The stock’s 50-day moving average is $12.75 and its 200 day moving average is $12.31. The company has a market cap of $8.65 billion, a P/E ratio of 542.97, a PEG ratio of 5.89 and a beta of 1.07.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on PATH shares. Canaccord Genuity Group dropped their price target on UiPath from $16.00 to $15.00 and set a “buy” rating on the stock in a research report on Monday, September 8th. BMO Capital Markets increased their price target on UiPath from $12.50 to $13.00 and gave the stock a “market perform” rating in a research report on Thursday, October 2nd. Zacks Research raised UiPath from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 8th. Cowen reissued a “hold” rating on shares of UiPath in a research report on Friday, September 5th. Finally, DA Davidson assumed coverage on UiPath in a research report on Friday, September 5th. They set a “neutral” rating and a $12.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, twelve have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $13.21.
View Our Latest Stock Report on UiPath
Insiders Place Their Bets
In other UiPath news, CAO Hitesh Ramani sold 10,000 shares of the firm’s stock in a transaction dated Monday, October 20th. The stock was sold at an average price of $15.65, for a total value of $156,500.00. Following the completion of the sale, the chief accounting officer owned 192,776 shares of the company’s stock, valued at approximately $3,016,944.40. This trade represents a 4.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Brad Brubaker sold 27,580 shares of the firm’s stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of $16.68, for a total value of $460,034.40. Following the completion of the sale, the insider directly owned 662,939 shares of the company’s stock, valued at approximately $11,057,822.52. This represents a 3.99% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 2,143,990 shares of company stock valued at $30,782,181. 23.19% of the stock is currently owned by corporate insiders.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
- Five stocks we like better than UiPath
- How Technical Indicators Can Help You Find Oversold Stocks
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- What Are Dividends? Buy the Best Dividend Stocks
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.